Safety and efficacy of rectal compared with intramuscular quinine for the early treatment of moderately severe malaria in children: Randomised clinical trial

British Medical Journal

Volumn 332, Issue 7549, 2006, Pages 1055-1057

  Barennes, Hubert ^a,d   Balima Koussoubé, Tatiana ^a   Nagot, Nicolas ^a   Charpentier, Jean Christophe ^b   Pussard, Eric ^c  

^a CENTRE MURAZ   (Burkina Faso)

^b Methodology and Research Centre   (France)

^c BICÊTRE HOSPITAL   (France)

^d Institut de la Francophonie Pour la Medicine Tropicale   (Laos)

Author keywords

[No Author keywords available]

Indexed keywords

QUINIMAX; QUININE; ANTIMALARIAL AGENT;

ABSCESS; ADOLESCENT; ANUS PRURITUS; ARTICLE; BURKINA FASO; CHILD; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DISEASE SEVERITY; DOSE RESPONSE; DRUG EFFICACY; DRUG SAFETY; FECES ANALYSIS; FEVER; HEMATOCHEZIA; HUMAN; INFLAMMATION; LABORATORY TEST; MAJOR CLINICAL STUDY; MALARIA; OUTCOME ASSESSMENT; PAIN; PARESTHESIA; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SYMPTOMATOLOGY; TREATMENT FAILURE; INFANT; INTRAMUSCULAR DRUG ADMINISTRATION; MALARIA FALCIPARUM; PRESCHOOL CHILD; RECTAL DRUG ADMINISTRATION; TREATMENT OUTCOME;

ADMINISTRATION, RECTAL; ADOLESCENT; ANTIMALARIALS; CHILD; CHILD, PRESCHOOL; HUMANS; INFANT; INJECTIONS, INTRAMUSCULAR; MALARIA, FALCIPARUM; QUININE; TREATMENT OUTCOME;

EID: 33646491176     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. World Health Organization. Severe falciparum malaria. Trans R Soc Trop Med Hyg 2000;94(suppl 1)(3rd ed):1-90.
2. Simonsen L, Kane A, Lloyd J, Zaffran M, Kane M. Unsafe injections in the developing world and transmission of bloodborne pathogens: a review. Bull WHO 1999;77:789-800.
3. Van Hoogdalem EJ, De Boer AG, Breimer DD. Pharmacokinetics of rectal drug administration. Part I. General considerations and clinical applications of centrally acting drugs. Clin Pharmacokinet 1991;21:11-26.
4. Barennes H, Kahiatani F, Pussard E, Clavier F, Meynard D, Njifountawouo S, et al. Intrarectal Quinimax for the treatment of Plasmodium falciparum malaria in children in Niger: efficacy and pharmacokinetics. Trans R Soc Trop Med Hyg 1995;89:418-21.
5. Barennes H, Pussard E, Mahaman SA, Clavier F, Kahiatani F, Granic G, et al. Efficacy and pharmacokinetics of a new intrarectal quinine formulation in children with Plasmodium falciparum malaria. Br J Clin Pharmacol 1996;41:389-95.
6. Barennes H, Munjakazi JM, Verdier F, Clavier F, Pussard E. An open randomized clinical study of intrarectal versus infused Quinimax for me treatment of childhood cerebral malaria in Niger. Trans R Soc Trop Med Hyg 1998;92:437-40.
7. Barennes H, Daouda K, Pussard E, Munjakazi JM, Fernan M, Sherouat H, et al. Administration intrarectale de la quinine: un traitement précoce du paludisme grave de l'enfant? Cahiers Santé 2001;11:145-53.
8. Del Nero L, Lamizana L, Nebie I, Sare S, Bougouma L, Pietra V. In vivo sensitivity of Plasmodium falciparum to halofantrine hydrochloride in Burkina Faso. Am J Trop Med Hyg 1994;50:102-6.
9. Pussard E, Straczek C, Kaboré I, Bicaba B, Balima-Koussoubé T, Bourrée P, et al. Dose-dependent resorption of quinine after intrarectal administration to children with moderate falciparum malaria. Antimicrob Agents Chemother 2004;48(11):4422-6.
10. World Health Organization. Monitoring antimalarial drug resistance. Report of a WHO consultation. Geneva: WHO, 2001.
11. Barennes H, Mahaman S, Munjakazi JM, Khenine A. Tolérance de la quinine en solution intrarectale chez l'enfant Africain. Med Trop 1999;59:383-7.
12. Harouna Y, Gamatié Y, Gamatié S, Mounkaila H, Boureima M. A propos de deux complications chirurgicales graves de l'usage de la quinine intramusculaire et intrarectale. Bull Soc Pathol Exot 2000;93:328-30.